Sleeping beauty: a novel cancer gene discovery tool

被引:32
作者
Dupuy, AJ [1 ]
Jenkins, NA [1 ]
Copeland, NG [1 ]
机构
[1] Natl Canc Inst, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA
关键词
D O I
10.1093/hmg/ddl061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The National Cancer Institute and the National Human Genome Research Institute recently announced a 3-year 100-million-dollar pilot study to use large-scale resequencing of genes in human tumors to identify new cancer genes. The hope is that some of these genes can be used as drug targets for developing better therapeutics for treating cancer. Although this effort will identify new cancer genes, it could be made more efficient by preferentially resequencing genes identified as novel candidate cancer genes in animal models of cancer. Although retroviral insertional mutagenesis has proven to be an effective tool for identifying novel cancer genes in the mouse, these studies are limited by the fact that retroviral mutagenesis primarily induces hematopoietic and mammary cancer, but little else, while the majority of cancers affecting humans are solid tumors. Recently, two groups have shown that sleeping beauty (SB) transposon-based insertional mutagenesis can also identify novel candidate cancer genes in the mouse. Unlike retroviral infection, SB transposition can be controlled to mutagenize any target tissue and thus potentially induce many different kinds of cancer, including solid tumors. SB transposition in animal models of cancer could therefore greatly facilitate the identification of novel human cancer genes and the development of better cancer therapies.
引用
收藏
页码:R75 / R79
页数:5
相关论文
共 37 条
[1]   MMTV-induced mutations in mouse mammary tumors: Their potential relevance to human breast cancer [J].
Callahan, R .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 39 (01) :33-44
[2]   Imatinib resistance in gastrointestinal stromal tumors [J].
Chen L.L. ;
Sabripour M. ;
Andtbacka R.H.I. ;
Patel S.R. ;
Feig B.W. ;
Macapinlac H.A. ;
Choi H. ;
Wu E.F. ;
Frazier M.L. ;
Benjamin R.S. .
Current Oncology Reports, 2005, 7 (4) :293-299
[3]   Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse [J].
Collier, LS ;
Carlson, CM ;
Ravimohan, S ;
Dupuy, AJ ;
Largaespada, DA .
NATURE, 2005, 436 (7048) :272-276
[4]   Structure-function analysis of the inverted terminal repeats of the Sleeping Beauty transposon [J].
Cui, ZB ;
Geurts, AM ;
Liu, GY ;
Kaufman, CD ;
Hackett, PB .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 318 (05) :1221-1235
[5]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[6]   Array CGH technologies and their applications to cancer genomes [J].
Davies, JJ ;
Wilson, IM ;
Lam, WL .
CHROMOSOME RESEARCH, 2005, 13 (03) :237-248
[7]  
De Giorgi U, 2005, MOL CANCER THER, V4, P495
[8]   The development of imatinib as a therapeutic agent for chronic myeloid leukemia [J].
Deininger, M ;
Buchdunger, E ;
Druker, BJ .
BLOOD, 2005, 105 (07) :2640-2653
[9]  
Deininger Michael, 2005, J Natl Compr Canc Netw, V3, P757
[10]   Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system [J].
Dupuy, AJ ;
Akagi, K ;
Largaespada, DA ;
Copeland, NG ;
Jenkins, NA .
NATURE, 2005, 436 (7048) :221-226